ARSMX
Price
$10.44
Change
+$0.11 (+1.06%)
Updated
Jul 24 closing price
Net Assets
343.04M
SSGSX
Price
$53.42
Change
+$0.34 (+0.64%)
Updated
Jul 24 closing price
Net Assets
4.51B
Interact to see
Advertisement

ARSMX vs SSGSX

ARSMX vs SSGSX Comparison Chart in %
View a ticker or compare two or three
VS
ARSMX vs. SSGSX commentary
Jul 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARSMX is a Hold and SSGSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SSGSX has more cash in the bank: 4.51B vs. ARSMX (343M). SSGSX pays higher dividends than ARSMX: SSGSX (0.51) vs ARSMX (0.22). ARSMX was incepted earlier than SSGSX: ARSMX (19 years) vs SSGSX (27 years). ARSMX (1.28) and SSGSX (1.23) have similar cost to investors . SSGSX is a more actively managed with annual turnover of: 50.00 vs. ARSMX (36.00). ARSMX has a lower initial minimum investment than SSGSX: ARSMX (2000) vs SSGSX (2500). SSGSX annual gain was more profitable for investors over the last year : 19.33 vs. ARSMX (5.59). ARSMX return over 5 years is better than : 9.71 vs. SSGSX (1.07).
ARSMXSSGSXARSMX / SSGSX
Total Expense Ratio1.281.23104%
Annual Report Gross Expense Ratio1.281.23104%
Fund Existence19 years27 years-
Gain YTD9.54919.53549%
Front LoadN/A6%-
Min. Initial Investment2000250080%
Min. Initial Investment IRAN/AN/A-
Net Assets343M4.51B8%
Annual Yield % from dividends0.220.5143%
Returns for 1 year5.5919.3329%
Returns for 3 years15.009.95151%
Returns for 5 years9.711.07908%
Returns for 10 years47.0341.58113%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NSP48.350.37
+0.77%
Insperity
KYMR110.570.19
+0.17%
Kymera Therapeutics
FGBIP19.41-0.42
-2.12%
First Guaranty Bancshares
MCRB4.97-0.27
-5.07%
Seres Therapeutics Inc
CTEV21.61-1.66
-7.13%
Claritev Corporation